[Problems specific to chemotherapy of intracerebral tumors].
D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D001812:Blood-Brain Barrier; D001932:Brain Neoplasms / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D002273:Carcinogens; D002415:Cats; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D010478:Chemotherapy, Cancer, Regional Perfusion; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005500:Follow-Up Studies; D000882:Haplorhini; D006801:Humans; D008748:Methylcholanthrene; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009607:Nitrosourea Compounds; D051381:Rats
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D002273:Carcinogens; D009607:Nitrosourea Compounds; D008748:Methylcholanthrene
Problémes particuliers a la chimiothérapie des tumeurs intra-cérébrales